Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17060489rdf:typepubmed:Citationlld:pubmed
pubmed-article:17060489lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:17060489lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:17060489lifeskim:mentionsumls-concept:C0010798lld:lifeskim
pubmed-article:17060489lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:17060489lifeskim:mentionsumls-concept:C0449438lld:lifeskim
pubmed-article:17060489lifeskim:mentionsumls-concept:C0746883lld:lifeskim
pubmed-article:17060489lifeskim:mentionsumls-concept:C0333348lld:lifeskim
pubmed-article:17060489lifeskim:mentionsumls-concept:C0033522lld:lifeskim
pubmed-article:17060489pubmed:issue1lld:pubmed
pubmed-article:17060489pubmed:dateCreated2007-1-15lld:pubmed
pubmed-article:17060489pubmed:abstractTextWe hypothesized that cancer-related inflammation might increase the risk of febrile neutropenia (FN) induced by docetaxel (DCX, Taxotere), by both affecting the exposure to DCX and the tissue sensitivity.lld:pubmed
pubmed-article:17060489pubmed:languageenglld:pubmed
pubmed-article:17060489pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17060489pubmed:citationSubsetIMlld:pubmed
pubmed-article:17060489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17060489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17060489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17060489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17060489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17060489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17060489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17060489pubmed:statusMEDLINElld:pubmed
pubmed-article:17060489pubmed:monthJanlld:pubmed
pubmed-article:17060489pubmed:issn0923-7534lld:pubmed
pubmed-article:17060489pubmed:authorpubmed-author:SHOYYlld:pubmed
pubmed-article:17060489pubmed:authorpubmed-author:PonsGGlld:pubmed
pubmed-article:17060489pubmed:authorpubmed-author:GrabanWWlld:pubmed
pubmed-article:17060489pubmed:authorpubmed-author:AlexandreJJlld:pubmed
pubmed-article:17060489pubmed:authorpubmed-author:TranAAlld:pubmed
pubmed-article:17060489pubmed:authorpubmed-author:DierasVVlld:pubmed
pubmed-article:17060489pubmed:authorpubmed-author:HéraitPPlld:pubmed
pubmed-article:17060489pubmed:authorpubmed-author:GoldwasserFFlld:pubmed
pubmed-article:17060489pubmed:authorpubmed-author:JullienVVlld:pubmed
pubmed-article:17060489pubmed:authorpubmed-author:GirreVVlld:pubmed
pubmed-article:17060489pubmed:authorpubmed-author:TreluyerJ-MJMlld:pubmed
pubmed-article:17060489pubmed:authorpubmed-author:RabillonFFlld:pubmed
pubmed-article:17060489pubmed:authorpubmed-author:MontheilVVlld:pubmed
pubmed-article:17060489pubmed:issnTypePrintlld:pubmed
pubmed-article:17060489pubmed:volume18lld:pubmed
pubmed-article:17060489pubmed:ownerNLMlld:pubmed
pubmed-article:17060489pubmed:authorsCompleteYlld:pubmed
pubmed-article:17060489pubmed:pagination168-72lld:pubmed
pubmed-article:17060489pubmed:meshHeadingpubmed-meshheading:17060489...lld:pubmed
pubmed-article:17060489pubmed:meshHeadingpubmed-meshheading:17060489...lld:pubmed
pubmed-article:17060489pubmed:meshHeadingpubmed-meshheading:17060489...lld:pubmed
pubmed-article:17060489pubmed:meshHeadingpubmed-meshheading:17060489...lld:pubmed
pubmed-article:17060489pubmed:meshHeadingpubmed-meshheading:17060489...lld:pubmed
pubmed-article:17060489pubmed:meshHeadingpubmed-meshheading:17060489...lld:pubmed
pubmed-article:17060489pubmed:meshHeadingpubmed-meshheading:17060489...lld:pubmed
pubmed-article:17060489pubmed:meshHeadingpubmed-meshheading:17060489...lld:pubmed
pubmed-article:17060489pubmed:meshHeadingpubmed-meshheading:17060489...lld:pubmed
pubmed-article:17060489pubmed:meshHeadingpubmed-meshheading:17060489...lld:pubmed
pubmed-article:17060489pubmed:meshHeadingpubmed-meshheading:17060489...lld:pubmed
pubmed-article:17060489pubmed:meshHeadingpubmed-meshheading:17060489...lld:pubmed
pubmed-article:17060489pubmed:meshHeadingpubmed-meshheading:17060489...lld:pubmed
pubmed-article:17060489pubmed:meshHeadingpubmed-meshheading:17060489...lld:pubmed
pubmed-article:17060489pubmed:meshHeadingpubmed-meshheading:17060489...lld:pubmed
pubmed-article:17060489pubmed:meshHeadingpubmed-meshheading:17060489...lld:pubmed
pubmed-article:17060489pubmed:meshHeadingpubmed-meshheading:17060489...lld:pubmed
pubmed-article:17060489pubmed:year2007lld:pubmed
pubmed-article:17060489pubmed:articleTitleRelationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study.lld:pubmed
pubmed-article:17060489pubmed:affiliationDepartment of Medical Oncology, Groupe Hospitalier Cochin St Vincent de Paul, Université Paris 5, Assistance Publique-Hôpitaux de Paris, Paris, France. jalexand@mdanderson.orglld:pubmed
pubmed-article:17060489pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17060489pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17060489lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17060489lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17060489lld:pubmed